elranatamab
pfizer
['multiple myeloma', 'elranatamab', 'pfizer']
elranatamab produces efficacy response in penta-or triple-class refractory multiple myeloma #ash22 
Patient & CEO at @IMFMYELOMA  https://t.co/uQjumfRX1I | 26  year #myeloma patient https://t.co/Fj5nMt9Zmq | Personal views